1. Home
  2. RGC vs PIM Comparison

RGC vs PIM Comparison

Compare RGC & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
    SELLHOLDBUYas of 3 days ago
  • PIM
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • RGC 2014
  • PIM 1988
  • Country
  • RGC Hong Kong
  • PIM United States
  • Employees
  • RGC N/A
  • PIM N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • PIM Finance Companies
  • Sector
  • RGC Health Care
  • PIM Finance
  • Exchange
  • RGC Nasdaq
  • PIM Nasdaq
  • Market Cap
  • RGC 105.3M
  • PIM 158.0M
  • IPO Year
  • RGC 2021
  • PIM N/A
  • Fundamental
  • Price
  • RGC $4.82
  • PIM $3.28
  • Analyst Decision
  • RGC
  • PIM
  • Analyst Count
  • RGC 0
  • PIM 0
  • Target Price
  • RGC N/A
  • PIM N/A
  • AVG Volume (30 Days)
  • RGC 6.7K
  • PIM 57.5K
  • Earning Date
  • RGC 10-25-2024
  • PIM 01-01-0001
  • Dividend Yield
  • RGC N/A
  • PIM 8.28%
  • EPS Growth
  • RGC N/A
  • PIM N/A
  • EPS
  • RGC N/A
  • PIM 0.05
  • Revenue
  • RGC N/A
  • PIM N/A
  • Revenue This Year
  • RGC N/A
  • PIM N/A
  • Revenue Next Year
  • RGC N/A
  • PIM N/A
  • P/E Ratio
  • RGC N/A
  • PIM $63.80
  • Revenue Growth
  • RGC N/A
  • PIM N/A
  • 52 Week Low
  • RGC $3.03
  • PIM $2.90
  • 52 Week High
  • RGC $32.44
  • PIM $3.28
  • Technical
  • Relative Strength Index (RSI)
  • RGC 44.37
  • PIM 52.34
  • Support Level
  • RGC $4.81
  • PIM $3.21
  • Resistance Level
  • RGC $4.95
  • PIM $3.30
  • Average True Range (ATR)
  • RGC 0.24
  • PIM 0.04
  • MACD
  • RGC 0.03
  • PIM 0.00
  • Stochastic Oscillator
  • RGC 19.92
  • PIM 81.25

Stock Price Comparison Chart: RGC vs PIM

RGC
PIM
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202505101520253035404550RGC VS PIM

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use